Manager/Sr. Manager, Scientific Communications and Publications
BridgeBio Pharma
Summary
The Scientific Communications and Publications Manager/Sr Manager will provide medical writing and operational support to the Scientific Communications and Publications Strategy team within Medical Affairs. This position will work closely with the Executive Director of Scientific Communications and Publication Strategy to develop and implement scientific communication and publication plans for BridgeBio Skeletal Dysplasia in alignment with business objectives.
Job description
What You'll Do
The Scientific Communications and Publications Manager/Sr Manager will provide medical writing and operational support to the Scientific Communications and Publications Strategy team within Medical Affairs. This position will work closely with the Executive Director of Scientific Communications and Publication Strategy to develop and implement scientific communication and publication plans for BridgeBio Skeletal Dysplasia in alignment with business objectives.
Responsibilities
- Contribute to content development of a diverse range of deliverables within medical publications and scientific communications
- Contribute to publication and communication plans
- Support publication activities including collecting author agreements and financial disclosures, overseeing the publication review process, and managing abstract and conference submissions
- Create and maintain accurate and complete records of all publication activities in compliance with BridgeBio SOPs and industry standards
- Manage tactical scientific communication activities to ensure timelines and deliverables are maintained
- Ensures all outputs and activities meet the highest standards of scientific integrity and comply with industry standards
- Other associated tasks as required
Where You'll Work
This is a remote role with travel as necessary for company meetings and events.
Who You Are
- Master's degree (or higher) in a scientific discipline is required
- A minimum of 2 years of experience developing content for medical publications is required, preferably in the biotech/pharmaceutical industry
- Excellent medical writing skills in English is a requirement
- Exceptional communication and interpersonal skills are required to interact effectively with internal and external stakeholders
- Ability to understand, interpret, and effectively communicate complex scientific data
- Ability to work efficiently independently as well as in cross-functional teams in fast-paced environments
- Ability to manage multiple priorities and meet deadlines
- Proficiency in commonly used word processing, graphic, and bibliographic software
- Ability to travel approximately 10% is required
- Must be able to work during Pacific Time Zone working hours
- Must be legally authorized to work in the United States
Requirements
- Master's degree (or higher) in a scientific discipline
- Minimum 2 years of experience developing content for medical publications
- Excellent medical writing skills in English
- Exceptional communication and interpersonal skills
- Ability to understand, interpret, and effectively communicate complex scientific data
- Ability to work independently and in cross-functional teams
- Ability to manage multiple priorities and meet deadlines
- Proficiency in word processing, graphic, and bibliographic software
- Ability to travel approximately 10%
- Must be able to work during Pacific Time Zone working hours
- Must be legally authorized to work in the United States
Benefits
- 401(k) Matching
- Employee Stock Purchase Program
- Pre-tax Commuter Benefits
- Referral Bonus
- Subsidized Lunch
- Subsidized Parking
- Medical, Dental & Vision
- Health Savings Account
- Flexible Spending Accounts
- Fertility & Family-Forming Benefits
- Mental Health Support
- Paid Time Off
- Paid Medical Leave
- Paid Parental Leave
Company overview
BridgeBio Pharma is a pioneering biopharmaceutical company founded in 2015 with a mission to discover, create, test, and deliver transformative medicines for patients suffering from genetic diseases. Headquartered in Palo Alto, California, the company operates as a new type of biopharmaceutical organization that bridges the gap between remarkable advancements in genetic science and patients with unmet medical needs. BridgeBio focuses on Mendelian diseases, which arise from defects in a single gene, and cancers with clear genetic drivers. The company's innovative approach involves identifying and advancing promising scientific discoveries through a portfolio model that spans early discovery to late-stage development. With a pipeline of over 20 development programs, BridgeBio employs a team of experienced drug discoverers, developers, and innovators committed to applying advances in genetic medicine to help patients as quickly as possible. The company's business model combines scientific expertise with entrepreneurial execution to address rare genetic conditions that have historically been overlooked by traditional pharmaceutical companies due to small patient populations and industry reluctance to conduct early-stage development.